European Association of Urology - Early detection of #prostatecancer is vital. 📖 Check out the newly updated #EAUGuidelines recommendations: uroweb.org/guidelines/prostate-cancer 🎧 Or listen to Prof. Nicolas Mottet review the update on #EAUPodcasts:
![Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1532046415000805-fx1.jpg)
Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283812008342-gr2.jpg)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect
Indonesian Prostate Cancer Risk Calculator (IPCRC): An application for Predicting Prostate Cancer Risk (a Multicenter Study)
![JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy](https://pub.mdpi-res.com/jpm/jpm-09-00019/article_deploy/html/images/jpm-09-00019-g001.png?1571415812)
JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov-2-FI.jpg)
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
![Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study](https://www.frontiersin.org/files/Articles/693684/fonc-11-693684-HTML/image_m/fonc-11-693684-g001.jpg)
Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study
![IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis](https://www.mdpi.com/ijms/ijms-20-01637/article_deploy/html/images/ijms-20-01637-g001.png)
IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
![Development and usability testing of the smartphone application Rotterdam Prostate Cancer Risk Calculator Development and usability testing of the smartphone application Rotterdam Prostate Cancer Risk Calculator](https://abstracts.mirrorsmed.org/sites/default/files/abstracts/development-and-usability-testing-smartphone-application-rotterdam-prostate-cancer-risk-calculator/figure1.png)
Development and usability testing of the smartphone application Rotterdam Prostate Cancer Risk Calculator
![Brief, intense radiation and hormone therapy for very high-risk prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK Brief, intense radiation and hormone therapy for very high-risk prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2021/06/pic_x.png)
Brief, intense radiation and hormone therapy for very high-risk prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
![CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2011/06/capra-s-rev.png?w=640)
CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK
![IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies](https://www.mdpi.com/ijms/ijms-24-02449/article_deploy/html/images/ijms-24-02449-g001.png)
IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies
![Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/asset/a9ff3c6d-b2c8-4218-97ab-9d8b49da6cee/gr1.jpg)